Funding · Company

Proxima Bio, Inc.

New York, NYHealthcare

Proxima Bio, Inc. of New York, NY has disclosed $91M across 1 Form D offering filed with the SEC on Jun 10, 2026.

$91M

Total disclosed

Form D offering

Offerings on file

Each amount is as reported on that filing, cumulative across its own amendments. Newest first.

$91M

Form D · Jun 10, 2026 ↗

Q2 2026 · 1 amendment, first filed Jan 21, 2026

Filing details

HeadquartersNew York, NYIndustryHealthcare (Other Health Care)SEC CIK0002104665Offerings on file1

Links

All SEC filings for this company ↗ proximabio.com ↗ Startups in New York → More healthcare raises →

Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →